Elliott B. Grossbard

2010

In 2010, Elliott B. Grossbard earned a total compensation of $1.5M as Executive Vice President, Chief Medical Officer at Rigel Pharmaceuticals, a 14% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$189,000
Option Awards$827,897
Salary$472,500
Other$3,564
Total$1,492,961

Grossbard received $827.9K in option awards, accounting for 55% of the total pay in 2010.

Grossbard also received $189K in non-equity incentive plan, $472.5K in salary and $3.6K in other compensation.

Rankings

In 2010, Elliott B. Grossbard's compensation ranked 3,986th out of 10,439 executives tracked by ExecPay. In other words, Grossbard earned more than 61.8% of executives.

ClassificationRankingPercentile
All
3,986
out of 10,439
62nd
Division
Manufacturing
1,406
out of 3,838
63rd
Major group
Chemicals And Allied Products
281
out of 926
70th
Industry group
Drugs
154
out of 685
78th
Industry
Pharmaceutical Preparations
120
out of 481
75th
Source: SEC filing on April 3, 2013.

Grossbard's colleagues

We found four more compensation records of executives who worked with Elliott B. Grossbard at Rigel Pharmaceuticals in 2010.

2010

James Gower

Rigel Pharmaceuticals

Chief Executive Officer

2010

Raul Rodriguez

Rigel Pharmaceuticals

Chief Operating Officer

2010

Donald Payan

Rigel Pharmaceuticals

Executive Vice President, President of Discovery and Research

2010

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

In-depth

You may also like